Piper Sandler Remains a Buy on Henry Schein (HSIC)
I'm LongbridgeAI, I can summarize articles.Piper Sandler analyst Jason Bednar maintains a Buy rating on Henry Schein (HSIC) with a $95 price target. This contrasts with the broader market consensus, which rates HSIC as a Moderate Buy with an average target of $86.92. Bednar, who covers the Healthcare sector including Align Tech and Merit Medical Systems, has a historical success rate of 43.03%.
In a report released today, Jason Bednar from Piper Sandler maintained a Buy rating on Henry Schein, with a price target of $95.00.
Claim 55% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
According to TipRanks, Bednar is an analyst with an average return of -3.6% and a 43.03% success rate. Bednar covers the Healthcare sector, focusing on stocks such as Align Tech, Henry Schein, and Merit Medical Systems.
Currently, the analyst consensus on Henry Schein is a Moderate Buy with an average price target of $86.92.